Journal profile · Pharmacology & Pharmacy
Clinical Pharmacology & Therapeutics
ISSN 0009-9236 · eISSN 1532-6535 · Wiley-Blackwell · UNITED STATES · Monthly · Founded 1960
Clinical Pharmacology & Therapeutics: CAS Zone 2 · Medicine (2025 upgraded edition); impact factor 4.85; hybrid open access; APC about USD 4,410; median 100 days to acceptance (106 articles, last 24 months); community-reported acceptance: about 25%; 433 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Clinical Pharmacology & Therapeutics is published by Wiley-Blackwell and is in Zone 2 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Pharmacogenetics and Drug Metabolism, Pharmaceutical studies and practices and Cancer Treatment and Pharmacology, together about 32.5% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Clinical Pharmacology & Therapeutics (CPT) is the authoritative cross-disciplinary journal in experimental and clinical medicine devoted to publishing advances in the nature, action, efficacy, and evaluation of therapeutics. CPT welcomes original Articles in the emerging areas of translational, predictive and personalized medicine; new therapeutic modalities including gene and cell therapies; pharmacogenomics, proteomics and metabolomics; bioinformation and applied systems biology complementing areas of pharmacokinetics and pharmacodynamics, human investigation and clinical trials, real world data/real world evidence (RWD/RWE), pharmacovigilence, pharmacoepidemiology, pharmacometrics, and population pharmacology. Commentaries and Perspectives provide a forum for perspectives in clinical pharmacology and therapeutics in the context of contemporary scientific, political, economic and social issues. State of the Art contributions summarize the latest advances in the science underpinning drug discovery, development, regulation and utilization. White Papers express the consensus of two or more organizations, working groups, consortia, etc. CPT highlights issues transforming the practice of clinical pharmacology, including ethics, education and public policy. Bench-to-bedside translation in therapeutics is presented in the context of clinical applications of basic pharmacology, discovery and translational medicine, and drug development.
From the journal's Aims & Scope
Research area (LetPub): Pharmacology & Pharmacy
Editor-in-chief Scott A. WaldmanPublisher website
Main research topics OpenAlex counts of recent articles; shares are approximate
- Pharmacogenetics and Drug MetabolismPharmacology, Toxicology and Pharmaceutics14.3%
- Pharmaceutical studies and practicesMedicine12.7%
- Cancer Treatment and PharmacologyMedicine5.5%
- Pharmacological Effects and Toxicity StudiesMedicine5.5%
- Drug Transport and Resistance MechanismsMedicine5.3%
- Antibiotics Pharmacokinetics and EfficacyMedicine4.9%
- Health Systems, Economic Evaluations, Quality of LifeEconomics, Econometrics and Finance4.8%
- Statistical Methods in Clinical TrialsMathematics4.3%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Pharmacology & Pharmacy | Zone 1 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Pharmacology & Pharmacy | Zone 1 |
Top journal: yesReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Pharmacology & Pharmacy | Zone 1 |
Top journal: yesReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
Web of ScienceMEDLINEPubMedEmbaseCAB AbstractsCINAHLCurrent ContentsPublisher website
Other: EBSCO, ProQuest
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 4.85LetPub ·
- Impact factor (publisher) 2025
- 4.9Publisher website ·
- CiteScore 2026-06
- 9.9LetPub ·
- CiteScore (publisher) 2025
- 9.9Publisher website ·
- SJR 2026-06
- 1.86LetPub ·
- SNIP 2026-06
- 1.72LetPub ·
- h-index
- 173LetPub ·
- h-index
- 273OpenAlex ·
- i10-index
- 9,386OpenAlex ·
- 2-year mean citedness
- 4.06OpenAlex ·
- Self-citation rate
- 10.2%LetPub ·
- Share of gold OA articles
- 53.38%LetPub ·
Volume
- Articles per year
- 305LetPub ·
- Articles per year (publisher) 2025
- 358Publisher website ·
- Downloads per year (publisher) 2025
- 1,801,779Publisher website ·
Articles by year OpenAlex count · 19,015 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 325 | 259 | 170 |
| 2025 | 433 | 309 | 1,655 |
| 2024 | 392 | 285 | 2,848 |
| 2023 | 342 | 246 | 4,244 |
| 2022 | 326 | 194 | 6,517 |
| 2021 | 387 | 218 | 10,110 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
100 daysMedian, submission to acceptance · P25–P75 69 days – 129 days
- Acceptance to online
- median 20 days (107 articles)
- Submission to online
- median 120 days
- Sample
- 106 articles with submission and acceptance dates (819 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 2 monthsLetPub ·
- Average acceptance (community reports)
- 25%LetPub ·
- Acceptance rate (publisher) 2025
- 24%Publisher website ·
- Submission to first decision 2025
- 11 daysPublisher website ·
- Submission to acceptance 2025
- 87 daysPublisher website ·
- Acceptance to publication 2025
- 23 daysPublisher website ·
- Peer review
- Single-anonymous peer reviewPublisher website · model-extracted
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 4,410 / EUR 3,750 / GBP 3,360 | — | — | |
| Publisher website | USD 3,840 / USD 4,630 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
Other charges and waivers (author guidelines)
- Page charges
- 3,840
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare5 items from the author guidelines
- Reference style
- Numbered, in order of citation
- Highlights
- Required
- Graphical abstract
- Optional
- Cover letter
- Required
- Not considered
- preprint
Article types accepted17
- articleArticle: substantial novel original research. See below for more information on clinical trial registration and CONSORT guidanceLength not stated
- brief reportArticle Type Word Count+ Abstract/Introduction Word Limit Reference Limit Figures/Tables Article: substantial novel original research. See below for more inform…Length not stated
- commentaryArticle Type Word Count+ Abstract/Introduction Word Limit Reference Limit Figures/Tables Article: substantial novel original research. See below for more inform…Length not stated
- letterArticle Type Word Count+ Abstract/Introduction Word Limit Reference Limit Figures/Tables Article: substantial novel original research. See below for more inform…Length not stated
- letter to the editorArticle Type Word Count+ Abstract/Introduction Word Limit Reference Limit Figures/Tables Article: substantial novel original research. See below for more inform…Length not stated
- letters to the editorArticle Type Word Count+ Abstract/Introduction Word Limit Reference Limit Figures/Tables Article: substantial novel original research. See below for more inform…Length not stated
- meta-analysisArticle Type Word Count+ Abstract/Introduction Word Limit Reference Limit Figures/Tables Article: substantial novel original research. See below for more inform…Length not stated
- mini-reviewMini-Review: A concise overview of recent advances in the specified subject area.Length not stated
- original researchArticle Type Word Count+ Abstract/Introduction Word Limit Reference Limit Figures/Tables Article: substantial novel original research. See below for more inform…Length not stated
- perspectiveArticle Type Word Count+ Abstract/Introduction Word Limit Reference Limit Figures/Tables Article: substantial novel original research. See below for more inform…Length not stated
- practice guidelinePractice Guideline**: Offers evidence-based recommendations to guide clinical decision-making, standardize care, and improve patient outcomes for a specific con…Length not stated
- reviewArticle Type Word Count+ Abstract/Introduction Word Limit Reference Limit Figures/Tables Article: substantial novel original research. See below for more inform…Length not stated
- state of the art reviewState of the Art Review**: Typically topical, comprehensive reviews, award lectures, keynote addresses, and State of the Art lectures.Length not stated
- systematic reviewArticle Type Word Count+ Abstract/Introduction Word Limit Reference Limit Figures/Tables Article: substantial novel original research. See below for more inform…Length not stated
- systematic review/meta-analysisSystematic Review/Meta-Analysis: Literature summary using explicit and reproducible methods to systematically search, critically appraise, and synthesize a spec…Length not stated
- tutorialReviews, commentaries, tutorials, and perspectives may use the following:Length not stated
- white paperWhite Paper**: An authoritative report to present best practices for addressing complex clinical pharmacology issues.Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Data availability, Publication ethics, License & copyright, Open access, Peer review, Plagiarism
- AI use Use of Artificial Intelligence (AI)
AI tools cannot be listed as authors, as they cannot be accountable for the work. AI tools may be used in drafting assistance or to help in developing figures and tables. These tools should only be used to improve readability and language. All AI use must be credited, either in the acknowledgements or methods section. Authors remain responsible for all work submitted under their name.
Source ↗Publisher website ·- Authorship Author Contributions
Original Research Articles (including brief reports and systematic reviews) require an Author Contributions section before the References. Note that the following 4 roles must be included:
Source ↗Publisher website ·- Conflicts of interest Conflicts of interest
CPT subscribes to the Uniform Requirements for Manuscripts Submitted to Biomedical Journals established by the International Committee of Medical Journal Editors. These principles require that participants in the peer review and publication process disclose all relationships that could be viewed as presenting a potential conflict of interest. Disclosures must include employment, consultancies, hon…
Source ↗Publisher website ·- Data availability
Data policy: data expected to be archived in an appropriate public repository; data accessibility statement required. Model summary
CPT expects that data supporting the results in the paper will be archived in an appropriate public repository.
Source ↗Publisher website ·- Publication ethics
Ethics: human subjects research requires IRB review and approval; IRB or IACUC approval must be cited in Methods. Model summary
Research projects involving human subjects require review and approval by an Institutional Review Board (IRB).
Source ↗Publisher website ·- License & copyright Open Access and License to Publish
Copyright: authors of original research grant exclusive License to Publish rather than assigning copyright. Model summary
Open Access is available to authors who wish to make their article available to non-subscribers on publication, or whose funding agency requires grantees to archive the final version of their article. With Open Access, the author, the author’s funding agency, or the author’s institution pays a fee to ensure the article is made available to non-subscribers upon publication via Wiley Online Library,…
Source ↗Publisher website ·- Open access Open Access and License to Publish
Open Access available to authors who wish to make article available to non-subscribers or whose funding agency requires archiving. Model summary
Open Access is available to authors who wish to make their article available to non-subscribers on publication, or whose funding agency requires grantees to archive the final version of their article. With Open Access, the author, the author’s funding agency, or the author’s institution pays a fee to ensure the article is made available to non-subscribers upon publication via Wiley Online Library,…
Source ↗Publisher website ·- Peer review Peer Review Process
Peer review process: all manuscripts assessed by an Associate Editor; manuscripts not chosen for peer review returned to authors. Model summary
All manuscripts will be assessed by an Associate Editor. Manuscripts that are not chosen for peer review will be returned to the authors. If the Associate Editor chooses to send the manuscript for external peer review, reviewers will be assigned as noted below:
Source ↗Publisher website ·- Plagiarism Originality and Plagiarism
A submitted manuscript must be an original contribution not previously published (conference presentations nor posting on recognized preprint servers constitute prior publication), must not be under consideration for publication elsewhere, and, if accepted, must not be reproduced elsewhere without the consent of ASCPT. Although the editors, editorial board, and referees make every effort to ensure…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Wiley-Blackwell
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Monthly
- Founded
- 1960
- ISSN
- 0009-9236
- Electronic ISSN
- 1532-6535
- Latest issue on the website
- Volume 120, Issue 4 (October 2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Clinical Pharmacology & Therapeutics
What CAS zone is Clinical Pharmacology & Therapeutics in?
In the 2025 upgraded edition of the CAS Journal Ranking, Clinical Pharmacology & Therapeutics is in Zone 2 of Medicine, and in Zone 1 of the minor category Pharmacology & Pharmacy. In the 2026 Xinrui edition it is in Zone 2 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Clinical Pharmacology & Therapeutics?
The latest impact factor listed by LetPub is 4.85; CiteScore 9.9, h-index 273.
How long does peer review take at Clinical Pharmacology & Therapeutics?
Based on the dates recorded on 106 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 100 days (interquartile range 69–129 days); authors report an average review time of about 2 months; the community-reported acceptance is “about 25%”; the journal's website gives an acceptance rate of 24% (2025). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Clinical Pharmacology & Therapeutics?
According to the journal's author guidelines: Reference style: Numbered, in order of citation; Highlights: Required; Graphical abstract: Optional; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Which databases index Clinical Pharmacology & Therapeutics?
According to LetPub and DOAJ records, Clinical Pharmacology & Therapeutics is indexed in SCIE and Scopus. The journal's website also lists Web of Science, MEDLINE, PubMed, Embase, CAB Abstracts, CINAHL and Current Contents; that list has not been checked against each database.
Is Clinical Pharmacology & Therapeutics open access, and what is the APC?
Clinical Pharmacology & Therapeutics is a hybrid journal. For open-access publication: APC about USD 4,410.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .